Nora BE .35 mg/1 (Norethindrone TABLET) .35 mg/1

Nora BE .35 mg/1 is a progestin-only birth control tablet containing norethindrone. It is used for contraception and may help regulate menstrual cycles. This oral medication is manufactured by Teva Pharmaceuticals, Inc. in the USA.

Strength

.35 mg/1

Pack Size

6 PACKAGE in 1 CARTON (0480-3475-16) / 28 TABLET in 1 PACKAGE

Manufacturer / TM Owner

Teva Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nora BE .35 mg/1 is primarily used as a form of birth control. It works by preventing ovulation and altering the cervical mucus to hinder sperm movement. Some individuals may also use it to manage menstrual irregularities or reduce heavy bleeding. The primary active ingredient, norethindrone, is a synthetic progestin that mimics the natural hormone progesterone.

Side Effects

Common effects of Nora BE .35 mg/1 may include changes in menstrual bleeding patterns, such as lighter or more frequent periods. Some users may experience headaches, breast tenderness, or nausea. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

Nora BE .35 mg/1 should be used as directed by a healthcare provider. It is important to inform your healthcare provider about any existing medical conditions or allergies. This medication may not be suitable for everyone, particularly those with a history of blood clots or liver disease.

Avoid Interactions

Nora BE .35 mg/1 may interact with certain medications, including those that induce liver enzymes like rifampin or certain anticonvulsants. It is advisable to consult a healthcare provider before combining it with other medications. Alcohol consumption should be moderated, as it may affect the efficacy of the medication.

Frequently Asked Questions

Nora BE .35 mg/1 is primarily used for contraception and may help regulate menstrual cycles.

Nora BE .35 mg/1 is an oral tablet that should be taken daily at the same time each day.

Common side effects may include changes in menstrual bleeding, headaches, breast tenderness, and nausea.

It is important to consult a healthcare provider before combining Nora BE .35 mg/1 with other medications.

Nora BE .35 mg/1 may not be suitable for individuals with certain medical conditions, such as a history of blood clots or liver disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.